Development
U
e-therapeutics plc ETXPF
OTC PK
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)

07/31/2023 04/30/2023 01/31/2023 10/31/2022 07/31/2022
Total Cash And Short-Term Investments 20.40% 14.07% 10.18% 0.84% -39.61%
Total Receivables 69.83% 60.89% 0.73% -7.83% -28.17%
Inventory -- -- -- -- --
Prepaid Expenses 21.49% 15.10% 1.31% -7.29% 18.41%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets 22.79% 16.34% -6.60% -14.52% 32.52%
Total Current Assets 21.02% 14.65% 9.08% -0.17% -35.73%

Total Current Assets 21.02% 14.65% 9.08% -0.17% -35.73%
Net Property, Plant & Equipment -70.01% -71.59% -54.40% -58.26% 629.54%
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles 74.89% 65.60% 115.05% 96.78% 80.88%
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets -- -- -- -- --
Total Assets 19.20% 12.93% 7.72% -1.42% -33.97%

Total Accounts Payable 82.24% 72.65% 97.83% 81.12% -29.26%
Total Accrued Expenses -- -- -27.64% -33.78% --
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -76.50% -77.75% -30.75% -36.63% --
Total Finance Division Other Current Liabilities -- -- 304.40% 270.43% --
Total Other Current Liabilities -- -- 304.40% 270.43% --
Total Current Liabilities 23.41% 16.92% -1.95% -10.27% 12.38%

Total Current Liabilities 23.41% 16.92% -1.95% -10.27% 12.38%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -- -- -- -- --
Total Liabilities 14.11% 8.11% -18.12% -25.07% 21.53%

Common Stock & APIC 19.96% 13.65% 4.14% -4.69% -12.48%
Retained Earnings -20.13% -13.81% -2.12% 6.54% 1.15%
Treasury Stock & Other -- -- -- -- --
Total Common Equity 19.45% 13.16% 9.38% 0.11% -35.40%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity 19.45% 13.16% 9.38% 0.11% -35.40%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity 19.45% 13.16% 9.38% 0.11% -35.40%